Skip to content

Henry Schein HSIC Acquisition Related Indemnification

Acquisition Related Indemnification at other companies

Resideo Technologies, Inc. logo
Resideo Technologies, Inc.REZI
$0-100%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$0-100%
Amphenol logo
AmphenolAPH
$116.9M+166%
Zeta Global Holdings logo
Zeta Global HoldingsZETA
$22.3M-5.7%
Bruker logo
BrukerBRKR
$12.25M+341%
Everest Group logo
Everest GroupEG
$1.26B+6.2%

Other financials

Income statement

See full
Revenue$3.4B+6.3%
Gross profit$1.1B+7.0%
Operating income$182.0M+4.0%
Net income$107.0M-2.7%
EPS (diluted)$0.92+4.5%

Balance sheet

See full
Cash & equivalents$138.0M+8.7%
Total debt$3.7B+17.2%
Total equity$3.3B-1.3%
Total assets$11.3B+7.9%

Cash flow

See full
Operating cash flow-$97.0M-362%
CapEx$25.0M-19.4%
Free cash flow-$122.0M-2,133%

Valuation

See full
Market cap$9.1B-0.6%
Enterprise value$12.69B+4.2%
P/E23.1×+0.5×
P/S0.7×0.0×

Profitability

See full
Gross margin31.2%-0.4pp
Operating margin4.9%-0.2pp
Net margin3%-0.3pp
FCF margin3.3%-1.0pp

Returns & leverage

See full
Return on equity12%+0.2pp
Debt / equity1.1×+0.2×
Current ratio1.4×0.0×

Where this comes from

Reported directly by Henry Schein in its filing.

Tagged under the XBRL concept hsic:AcquisitionRelatedIndemnification.

The official record: Henry Schein’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Henry Schein's acquisition related indemnification.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Henry Schein's acquisition related indemnification?
Henry Schein (HSIC) reported acquisition related indemnification of $39M in Q4 2025.
What is the long-term trend for Henry Schein's acquisition related indemnification?
Over 3 years (2022 to 2025), Henry Schein's acquisition related indemnification has grown at a -12.9% compound annual growth rate (CAGR), from $59M to $39M.
What does acquisition related indemnification mean?
This represents assets or liabilities arising from contractual agreements where a seller indemnifies the company against specific risks or losses identified during an acquisition. It serves as a financial safeguard for the company post-merger. Tracking this helps investors understand the risk mitigation strategies employed during inorganic growth.